Anteris Technologies (AU:AVR) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Anteris Technologies Ltd has announced the issuance of 1,500 new fully paid Ordinary Shares, raising $15,000 through the conversion of unlisted options. The company, known for its innovative structural heart devices, including the DurAVR® transcatheter heart valve, is progressing in its mission to address unmet clinical needs in the structural heart market. The shares were issued under section 708A(5)(e) of the Corporations Act without the need for disclosure to investors.
For further insights into AU:AVR stock, check out TipRanks’ Stock Analysis page.